HealthcareDrug Discovery and DeliveryGene TherapyMicrofluidicsCell Therapy http://www.indeelabs.com ↗
Company facts
Early-stage
- Founded
- 2016
- Employees
- 5
- Headquarters
- United States
About
Intracellular delivery is the most problematic step in T cell immunotherapy discovery, development and manufacturing. Indee Labs is developing a non-viral intracellular delivery system based on microfluidic vortex shedding (µVS) to rapidly deliver nucleic acids, proteins and gene editing complexes to patient and donor T cells with minimal perturbation.